Rethymic Implant
- RxCUI
- 2626469
- RxNorm name
- Rethymic Implant
- Display name
- Rethymic Implant
- Full name
- Rethymic Implant
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125685 | Rethymic | allogeneic processed thymus tissue-agdc | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RETHYMIC | ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC | Sumitomo Pharma America, Inc. | e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | 2025-10-31 | Warnings, Adverse reactions | 2626469 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| e0022c28-8cda-4f1e-bcf1-1f440d37ec4a | RETHYMIC Implant [PSN] · allogeneic processed thymus tissue-agdc 220 SQCM Drug Implant [Rethymic] [SBD] · Rethymic 22,000 mm2 Implant [SY] · Rethymic 220 SQCM Implant [SY] · Rethymic Implant [SY] | 5 | 8 | These highlights do not include all the information needed to use RETHYMIC safely and effectively. See full prescribing information for RETHYMIC. RETHYMIC (Allogeneic processed thymus tissue–agdc) For surgical implantation Initial U.S. Approval: 2021 | 20251031 |